Gain Therapeutics, Inc. (GANX)

Price$1.80Cached quote
GANXNasdaq
Loading local price history

Financial charts

Total cash / debt

CashTotal debt

Financial statements

6 annual periodsNewest to oldest
202520242023202220212020
Revenue$0$0$55,180$132,640$133,928$28,881
Research & development$10.2M$10.8M$11.5M$8.4M$7.2M$2.3M
Operating expenses$18.7M$20.4M$22.3M$17.9M$14.0M$3.5M
Operating income−$18.7M−$20.4M−$22.3M−$17.8M−$13.8M−$3.5M
Operating margin——−40,328.26%−13,402.48%−10,323.59%−12,047.54%
EBITDA−$18.6M−$20.3M−$22.2M−$17.7M−$13.8M−$3.5M
EBITDA margin——−40,176.79%−13,354.10%−10,312.03%−12,014.32%
Net income−$20.2M−$20.4M−$22.3M−$17.6M−$13.9M−$3.6M
Net profit margin——−40,354.33%−13,262.02%−10,371.70%−12,387.67%
Basic EPSper basic share-$0.61-$0.89-$1.71-$1.48-$1.37-$1.33
Diluted EPSper diluted share-$0.61-$0.89-$1.71-$1.48-$1.37-$1.33

Owners

Reported shareholders

Reference date Jun 30, 2026
MARSHALL WACE, LLP · 4.44% of listed sharesCambridge Investment Research Advisors, Inc. · 2.62% of listed sharesPotomac Capital Management, Inc. · 2.18% of listed sharesIslam Khalid · ≈2.15% of listed sharesGSA CAPITAL PARTNERS LLP · 1.46% of listed sharesJONES FINANCIAL COMPANIES LLLP · 1.40% of listed sharesDME Capital Management, LP · 1.31% of listed sharesVANGUARD CAPITAL MANAGEMENT LLC · 1.11% of listed sharesGEODE CAPITAL MANAGEMENT, LLC · 1.05% of listed sharesRICHMAN ERIC I · ≈0.70% of listed sharesBlackRock, Inc. · 0.63% of listed sharesVANGUARD FIDUCIARY TRUST CO · 0.53% of listed sharesUBS Group AG · 0.50% of listed sharesStratos Wealth Partners, LTD. · 0.46% of listed sharesCresset Asset Management, LLC · 0.37% of listed sharesSTATE STREET CORP · 0.36% of listed sharesCITADEL ADVISORS LLC · 0.36% of listed sharesSquarepoint Ops LLC · 0.31% of listed sharesMORGAN STANLEY · 0.29% of listed sharesLPL Financial LLC · 0.27% of listed shares
4.44%of listed shares
MARSHALL WACE, LLP1.92M shares · Jun 30, 2026
View holders
Top 20 reported holders of GANX
Holder% owned
MARSHALL WACE, LLP
4.44%1.92M shares
Cambridge Investment Research Advisors, Inc.
2.62%1.14M shares
Potomac Capital Management, Inc.
2.18%946.4K shares
Islam Khalid
≈2.15%930.78K shares
GSA CAPITAL PARTNERS LLP
1.46%632.13K shares
JONES FINANCIAL COMPANIES LLLP
1.40%608.59K shares
DME Capital Management, LP
1.31%566.13K shares
VANGUARD CAPITAL MANAGEMENT LLC
1.11%480.27K shares
GEODE CAPITAL MANAGEMENT, LLC
1.05%453.5K shares
RICHMAN ERIC I
≈0.70%304.46K shares
BlackRock, Inc.
0.63%274.96K shares
VANGUARD FIDUCIARY TRUST CO
0.53%231.53K shares
UBS Group AG
0.50%215.01K shares
Stratos Wealth Partners, LTD.
0.46%200K shares
Cresset Asset Management, LLC
0.37%160K shares
STATE STREET CORP
0.36%157.54K shares
CITADEL ADVISORS LLC
0.36%154.52K shares
Squarepoint Ops LLC
0.31%136.36K shares
MORGAN STANLEY
0.29%125.97K shares
LPL Financial LLC
0.27%117.25K shares

Percentages use 43.34M shares of this listed class outstanding on Jun 30, 2026. ≈ compares the latest reported holding with a share total from a different date; it is not a confirmed current stake.

Gray completes the 100% scale. Reported positions may overlap; holders have different reporting dates.

Source: SEC Form 13F ↗Updated Sep 29, 2026 · Quarterly data

Insider buys & sells

Jul 1, 2024–Jun 30, 2026
Buys4$85.2K disclosed value
Sells (SEC code S)0$0.00 disclosed value
4 recent transactions
TransactionInsiderTypeSharesPriceValueOwned after
Aug 9, 2024Form 4Mack GeneCFO and Interim CEOBuyCommon Stock14.4K$1.01$14.5K14.4K
Aug 9, 2024Form 4Islam KhalidExecutive ChairmanBuyCommon Stock50.0K$1.00$50.0K50.0K
Jul 1, 2024Form 4RICHMAN ERIC IDirectorBuyCommon Stock12.0K$1.21$14.5K289.6K
Jul 1, 2024Form 4RICHMAN ERIC IDirectorBuyCommon Stock5.0K$1.23$6.2K277.6K

Community posts

It’s quiet here.

No posts about GANX yet. Start the conversation.

Write the first post